{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:16:38Z","timestamp":1792703798489,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T00:00:00Z","timestamp":1267142400000},"content-version":"vor","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ejphar.2009.02.037","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T04:12:02Z","timestamp":1235707922000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Antidepressant-like effects of melatonin in the mouse chronic mild stress model"],"prefix":"10.1016","volume":"607","author":[{"given":"Bernardo C.","family":"Detanico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo L.","family":"Piato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco L.","family":"Lhullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolney","family":"Caumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Elisabetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.02.037_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/archpsyc.1990.01810230054009","article-title":"Autoradiographic demonstration of increased serotonin 5-ht2 and beta-adrenergic-receptor binding-sites in the brain of suicide victims","volume":"47","author":"Arango","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/jpn.0421","article-title":"Implication of the hypothalamic\u2013pituitary\u2013adrenal axis in the physiopathology of depression","volume":"29","author":"Barden","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejphar.2009.02.037_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0447.1985.tb02531.x","article-title":"Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome","volume":"71","author":"Beck-Friis","year":"1985","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejphar.2009.02.037_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1139\/jpn.0414","article-title":"Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejphar.2009.02.037_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/ajp.142.7.811","article-title":"Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects","volume":"142","author":"Brown","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib6","article-title":"Effect of antidepressants on melatonin metabolite in depressed patients","author":"Carvalho","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0006-3223(96)00058-3","article-title":"Changes in sleep architecture following chronic mild stress","volume":"41","author":"Cheeta","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib8","first-page":"1215","article-title":"A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression","volume":"19","author":"Claustrat","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4530(02)00123-3","article-title":"Serum melatonin and urinary 6-sulfatoxymelatonin in major depression","volume":"29","author":"Crasson","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejphar.2009.02.037_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ejphar.2009.02.037_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neurobiolaging.2005.12.004","article-title":"Pinealectomy causes hippocampal CA1 and CA3 cell loss: reversal by melatonin supplementation","volume":"28","author":"De Butte","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2009.02.037_bib12","first-page":"670","article-title":"Drug evaluation: agomelatine targets a range of major depressive disorder symptoms","volume":"7","author":"Dubocovich","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2009.02.037_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.physbeh.2004.01.013","article-title":"Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice","volume":"81","author":"Ducottet","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2009.02.037_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0278-5846(03)00051-4","article-title":"Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice","volume":"27","author":"Ducottet","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(25)09543-6","article-title":"Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat","volume":"273","author":"Eison","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.02.037_bib16","first-page":"BR307","article-title":"Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test","volume":"12","author":"Ergun","year":"2006","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2009.02.037_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0149-7634(95)00052-6","article-title":"Melatonin effects on behavior: possible mediation by the central GABAergic system","volume":"20","author":"Golombek","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2009.02.037_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0031-9384(99)00096-7","article-title":"Corticosterone regulation of 5-HT2A receptor-mediated behaviors: attenuation by melatonin","volume":"67","author":"Gorzalka","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2009.02.037_bib19","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.092012099","article-title":"Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders","volume":"99","author":"Griebel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2009.02.037_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.physbeh.2005.02.011","article-title":"Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia","volume":"84","author":"Grippo","year":"2005","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2009.02.037_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mehy.2006.11.012","article-title":"The pattern of melatonin receptor expression in the brain may influence antidepressant treatment","volume":"69","author":"Hirsch-Rodriguez","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2009.02.037_bib22","first-page":"185","article-title":"Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain","volume":"2","author":"Imbesi","year":"2006","journal-title":"Int. J. Neuroprot. Neuroregener."},{"key":"10.1016\/j.ejphar.2009.02.037_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainresprot.2004.04.002","article-title":"Grooming analysis algorithm for neurobehavioural stress research","volume":"13","author":"Kalueff","year":"2004","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.ejphar.2009.02.037_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2009.02.037_bib25","first-page":"587","article-title":"Chronic melatonin treatment and the hypothalamo-pituitary\u2013adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release","volume":"89","author":"Konakchieva","year":"1997","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ejphar.2009.02.037_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008877-199902000-00007","article-title":"The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H\/He mice","volume":"10","author":"Kopp","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02245281","article-title":"Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors","volume":"108","author":"Kuroda","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.02.037_bib28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.euroneuro.2007.05.004","article-title":"Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target","volume":"17","author":"Lader","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yfrne.2004.08.001","article-title":"Human pineal physiology and functional significance of melatonin","volume":"25","author":"Macchi","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.02.037_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-079X.2006.00380.x","article-title":"Mechanisms involved in the antinociception caused by melatonin in mice","volume":"41","author":"Mantovani","year":"2006","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2009.02.037_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.euroneuro.2006.01.005","article-title":"Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission","volume":"16","author":"Micale","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/00008877-199511000-00003","article-title":"Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment","volume":"6","author":"Moreau","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2009.02.037_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1023\/A:1008688724058","article-title":"Melatonin and its physiological and therapeutic properties","volume":"20","author":"Nowak","year":"1998","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.ejphar.2009.02.037_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0706845","article-title":"Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents","volume":"149","author":"Nowak","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/frne.2000.0202","article-title":"Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry","volume":"22","author":"Pacchierotti","year":"2001","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib38","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","article-title":"Melatonin: nature's most versatile biological signal?","volume":"273","author":"Pandi-Perumal","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2009.02.037_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300091","article-title":"Effect of agomelatine in the chronic mild stress model of depression in the rat","volume":"28","author":"Papp","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2009.02.037_bib40","first-page":"9","article-title":"Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety","volume":"17","author":"Papp","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(00)02031-X","article-title":"Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis","volume":"860","author":"Raghavendra","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2009.02.037_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0924-977X(00)00115-2","article-title":"Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation","volume":"10","author":"Raghavendra","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2009.02.037_bib43","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/en.2007-1009","article-title":"Rhythmic expression of functional MT1 melatonin receptors in the rat adrenal gland","volume":"149","author":"Richter","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2009.02.037_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/187152707780363294","article-title":"GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action","volume":"6","author":"Sanacora","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejphar.2009.02.037_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11064-007-9518-3","article-title":"Innovative approaches for the treatment of depression: targeting the HPA axis","volume":"33","author":"Thomson","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2009.02.037_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-0327(90)90037-9","article-title":"Circadian rhythms in depression. Part II: circadian rhythms in inpatients with various mental disorders","volume":"18","author":"Tsujimoto","year":"1990","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ejphar.2009.02.037_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.brainresbull.2005.09.016","article-title":"Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating","volume":"68","author":"Weil","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2009.02.037_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2009.02.037_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","article-title":"Chronic mild stress (CMS) revisited: consistency and behavioural\u2013neurobiological concordance in the effects of CMS","volume":"52","author":"Willner","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2009.02.037_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2005.03.029","article-title":"Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol","volume":"514","author":"Yalcin","year":"2005","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:48Z","timestamp":1757974188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0014299909001769"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.037","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of melatonin in the mouse chronic mild stress model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}